Replication of the nonsegmented, plus-stranded RNA genome of Cucumber necrosis tombusvirus (CNV) requires two essential overlapping viral-coded replication proteins, the p33 replication co-factor and the p92 RNA-dependent RNA polymerase. In this paper, we demonstrate that p33 is phosphorylated in vivo and in vitro by a membrane-bound plant kinase. Phosphorylation of p33 was also demonstrated in vitro by using purified protein kinase C. The related p28 replication protein of Turnip crinkle virus was also found to be phosphorylated in vivo, suggesting that posttranslational modification of replication proteins is a general feature among members of the large Tombusviridae family. Based on in vitro studies with purified recombinant p33, we show evidence for phosphorylation of threonine and serine residues adjacent to the essential RNA-binding site in p33. Phosphorylation-mimicking aspartic acid mutations rendered p33 nonfunctional in plant protoplasts and in yeast, a model host. Comparable mutations within the prereadthrough portion of p92 did not abolish replication. The nonphosphorylation-mimicking alanine mutants of CNV were able to replicate in plant protoplasts and in yeast, albeit with reduced efficiency when compared to the wild type. These alanine mutants also showed altered subgenomic RNA synthesis and a reduction in the ratio between plus-and minus-strand RNAs produced during CNV infection. These findings suggest that phosphorylation of threonine/ serine residues adjacent to the essential RNA-binding site in the auxiliary p33 protein likely plays a role in viral RNA replication and subgenomic RNA synthesis during tombusvirus infections. D
Introduction
Replication of plus-strand RNA viruses, which are the most abundant among plant, animal, and human viruses, is performed by viral replicases (Ahlquist, 2002; Ahlquist et al., 2003; Buck, 1996) . The viral replicase consists of viral proteins, including the RNA-dependent RNA polymerase (RdRp), and putative host factors. In spite of their significance in virus replication, our current understanding of the roles of viral and host proteins is incomplete.
These proteins are likely subject to posttranslational modification(s), which could affect/regulate their functions in viral replication. Indeed, reversible phosphorylation and other posttranslational modifications are important for the functions of many cellular and viral proteins. For example, protein phosphorylation/dephosphorylation is frequently used as an ''on -off switch'', allowing regulation of protein function. While considerable information is available for the role of phosphorylation of replication proteins in minus-strand RNA viruses, which code for P replication protein, a phosphoprotein Lenard, 1999; Takacs et al., 1992) , the role and significance of phosphorylation of replication proteins in plus-strand RNA viruses are currently poorly understood. The examples include phosphorylation and ubiquitinyla-tion of Turnip yellow mosaic virus RNA-dependent RNA polymerase (RdRp) (Hericourt et al., 2000) and the Vpg of potyviruses (Puustinen et al., 2002) . Also, phosphorylation of CMV 2a RdRp protein was shown to occur late in infection, affecting its interaction with the 1a replication protein (a methyltransferase and helicase-like protein) (Kim et al., 2002) . Phosphorylation of the NS5A replication protein of hepatitis C virus (HCV) has been indicated to affect HCV replication and cellular signaling, likely facilitating establishment of chronic infections (Huang et al., 2004; Macdonald et al., 2004; Street et al., 2004) . Phosphorylation of the NS5B RdRp protein of HCV has been proposed to play critical role in HCV replication, based on enhanced HCV replication in cells overexpressing protein kinase C-related kinase 2 (PRK2, a host kinase), which is known to interact with NS5B (Kim et al., 2004) . In addition to the proposed role of phosphorylation in virus replication, posttranslational modification also affects the functions of other viral proteins, as demonstrated for movement (MP) and coat proteins (CP) of plus-stranded RNA viruses of plants (Ivanov et al., 2003; Waigmann et al., 2000) .
Tombusviruses are important and emerging plant pathogens that are among the best characterized plant viruses (White and Nagy, 2004) . They have monopartite, singlestranded RNA genomes of¨4.8 kb with mRNA-sense polarity. They belong to supergroup 2 viruses that include important plant pathogens (luteoviruses, carmoviruses, and others), human and animal pathogens (hepatitis C virus, flaviviruses, pestiviruses), and bacteriophages (Qbeta). Two of the five Tombusvirus-coded proteins, namely p33 and p92 (Fig. 1) , were shown to be essential for tombusvirus replication (Oster et al., 1998; Panaviene et al., 2005; Scholthof et al., 1995) and recombination . Both p33 and p92 are translated from the genomic RNA and p92 is the result of translational readthrough of the translation stop codon of p33 (Fig. 1) . Due to the protein expression strategy of tombusviruses, the N-terminal portion of p92 overlaps with p33 (Scholthof et al., 1995) . p92 contains the signature RdRp motifs and together with p33 is part of the tombusvirus replicase (Nagy and Pogany, 2000; Panaviene et al., 2004; Scholthof et al., 1995) . The essential p33 replication protein is proposed to function in template selection by specifically recognizing a conserved internally located stem-loop structure within the p92 ORF (Pogany et al., 2005) . Altogether, the p33 is likely involved in many essential replication functions, such as template RNA binding (Monkewich et al., 2005; Panavas et al., 2005; Pogany et al., 2005) , assembly/disassembly of the viral replicase complex (Panaviene et al., 2004 , targeting and/or attaching the replicase complexes to subcellular membranes (Navarro et al., 2004; Panavas et al., 2005) , complementary RNA synthesis, release of the newly made viral RNA Fig. 1 . Location of the predicted phosphorylation sites in the CNV replication proteins. (A) The CNV genomic RNA containing five open reading frames (indicated with boxes) and noncoding sequences (solid lines) is shown schematically. (B) The known functional domains in p33 are shown schematically at the top. The amino acid sequence of the RPR-motif and the predicted phosphorylation sites are shown for selected members of Tombusviridae. The following abbreviations were used: TBSV, Tomato bushy stunt virus (cherry strain); CNV, Cucumber necrosis virus; AMCV, Artichoke mottled crinkle virus; CymRSV, Cymbidium ringspot virus; PLV, Pear latent virus; PNSV, Pelargonium necrotic spot virus; CBV, Cucumber Bulgarian virus; CIRV, Carnation Italian ringspot virus; and TCV, Turnip crinkle virus (Carmovirus, Tombusviridae). progeny from the site of replication, and so on. Because posttranscriptional modifications of the replication proteins might play roles as molecular switches in the replication process by altering the properties of the replication proteins, we tested if the tombusvirus p33 is phosphorylated in infected plants. This study establishes that phosphorylation of the p33 replication protein takes place both in vivo and in vitro. Using kinase-containing plant extract, the phosphorylation sites were mapped to threonine/serine (T/S) residues located in the vicinity of the RNA-binding site, suggesting the possible role of phosphorylation in modulating the RNA-binding activity of p33. Using phosphorylation-mimicking aspartic acid (D) mutants of p33, we demonstrate that phosphorylation of the T/S residues in p33 could influence subgenomic versus genomic RNA synthesis and the ratio between plus-and minus-stranded RNAs. Phosphorylation incompetent alanine (A) mutants of CNV replicated slower than wild type in plant protoplast and showed less severe symptoms in Nicotiana benthamiana plants. In summary, our data promote a regulatory role for phosphorylation of p33 in tombusvirus replication.
Results

Rationale
Sequence comparison of p33 replication proteins of tombusviruses ( Fig. 1A) revealed the presence of conserved S and T residues (i.e., T 205 , S 210 , and T 211 ) adjacent to the previously identified arginine (R) and proline (P)-rich RNAbinding site (termed RPR-motif, R 213 P 214 R 215 R 216 R 217 P 218 ) ( Fig. 1B) . These S and T residues are likely phosphorylated in cells based on NetPhos analysis (i.e., they showed the probability of 0.8-0.9 relative value on a scale of 0.0 -1.0 for phosphorylation) (software: NetPhos, version 2.0, Technical University of Denmark) ( Fig. 1B ). Possible phosphorylation of these S and T residues in p33 would introduce negative charge in the vicinity of the positively charged RPR-motif, thus likely decreasing the RNA-binding capacity of p33. In support of this model, substitutions of A for arginines (R), which reduced the overall positive charge of the RPR motif, inhibited the ability of p33 to bind to the viral RNA as well as decreased tombusvirus replication in plant protoplasts . Based on these observations, we predicted that phosphorylation of p33 adjacent to the RPR-motif could be a regulatory ''switch'', affecting its biological function(s) in tombusvirus-infected cells.
In vivo phosphorylation of CNV p33 and the related TCV p28 replicase proteins
To test if the CNV p33 and the related TCV p28 replication proteins are phosphorylated in plants, first we enriched p33 and p28, respectively, in our samples by isolating membrane-enriched fractions from CNV and TCV-infected N. benthamiana plants [10 days postinoculation (dpi)]. This approach is based on previous findings that the membrane-fraction contains the active CNV and TCV replicases (Nagy and Pogany, 2000; Song and Simon, 1994) and the viral replication proteins ( Fig.  2A ) (Panaviene et al., 2004) . The obtained fractions were treated with SDS, followed by SDS-PAGE electrophoresis and blotting on PVDF membranes for Western blot analysis. We used antibody specifically recognizing either phosphorylated T or S residues for the Western blot assays (Kim et al., 2004) . Data obtained with the antiphosphothreonine antibody ( Fig. 2B ) showed that membrane-enriched fraction from CNV and TCV-infected plants contained phosphorylated T residues in p33 and p28, whereas healthy plants lacked similar proteins. In contrast, the anti-phosphoserine antibody-based assay was not sensitive enough to detect phosphorylated p33 and p28 (not shown). In addition, we also captured p33 with anti-p33 antibody from CNV-infected plants (using isolated membrane-enriched fraction, which was treated with 2% Triton X-100 to solubilize p33) on a protein A column, followed by elution. The recovered proteins were analyzed by SDS-PAGE, followed by staining with Pro-Q Diamond (Molecular Probes), a phosphoprotein-specific dye. This assay showed the presence of phosphorylated CNV p33 in plants ( Fig. 2C ). Overall, both the Western blot with phosphothreonine-specific antibody and the staining assay with phosphoprotein-specific dye demonstrated that the CNV p33 (and the related TCV p28) replication protein is phosphorylated at T residue(s) in infected cells.
In vitro phosphorylation of serine and threonine residues adjacent to the RNA-binding domain in p33
To determine if the conserved T 205 , S 210 , and T 211 residues located adjacent to the RNA-binding site in p33 ( Fig. 1A) can be phosphorylated, as predicted by NetPhos program, we developed an in vitro phosphorylation assay based on partially-purified kinase preparation obtained from healthy N. benthamiana plants. First, we prepared a membrane-enriched fraction from uninfected plants using the procedure developed for isolation of p33 (see above) and the CNV replicase (Panaviene et al., 2004) . Then, we performed a phosphorylation assay including the kinase in the membrane-enriched preparation, 32 P-labeled ATP, and purified peptides including or lacking the predicted phosphorylation sites adjacent to the RPR-motif in p33 ( Fig. 3 ). After the kinase reaction, the radioactively-labeled peptides were detected using SDS-PAGE/PhosphoImager analysis. This assay demonstrated that the peptide p33C 181 -240 containing the predicted T 205 , S 210 , and T 211 phosphorylation sites could be efficiently phosphorylated in vitro by the partially-purified plant kinase (Fig. 3A ). The second peptide (p33C 211 -240 ), which was not phosphorylated in this assay, lacked T 205 , S 210 residues and contained only T 211 residue in an unfavorable context ( Fig. 3A) . Overall, these experiments demonstrated that healthy N. benthamiana plants contain a membrane-associated kinase capable of phosphorylating p33 in vitro at one or more of the conserved T 205 , S 210 , and T 211 residues.
Based on NetPhos analysis, the probable kinase involved in phosphorylation of T 205 , S 210 , and T 211 residues in p33 is a protein kinase C (PKC)-like kinase. Interestingly, PKC-like kinase activity has been detected in plants (Lee and Lucas, Fig. 3 . In vitro phosphorylation of p33 by a plant kinase. (A) Two peptides derived from p33 were expressed as an MBP fusion in E. coli, affinitypurified, cleaved off from MBP with Factor Xa, and treated with a membrane-enriched preparation obtained from healthy N. benthamiana plants in the presence of g-[ 32 P]ATP. The arrowhead shows the phosphorylated peptide (p33 211 -240 ), whereas asterisk pinpoints the nonphosphorylated peptide (p33 219 -240 ). (B) Coomassie blue-stained SDS-PAGE shows the migration of the two peptides used in the phosphorylation assay. Fig. 4 . In vitro phosphorylation at S 210 and T 211 residues of p33 by PKC. (A) A p33-derived peptide (p33 205 -234 ) and its derivatives with the shown mutations were expressed as MBP fusions in E. coli, affinity-purified and treated with PKC in the presence of g-[ 32 P]ATP. The arrowheads show the phosphorylated peptides, whereas asterisks pinpoint phosphorylated PKC and high molecular weight proteins of unknown origin (B) Coomassie blue-stained SDS-PAGE shows the migration of the peptides (marked with an arrowhead) used in the phosphorylation assay. (C) Detection of PKC-mediated phosphorylation of S 210 using anti-phosphoserine antibody. The reagents used in this assay were the same as in panel A. After the in vitro phosphorylation assay, the samples were loaded on an SDS-PAGE gel, blotted to a PVDF membrane, and treated with anti-phosphoserine antibody. Additional details are as described in panel A. Sokolova et al., 1997) . Therefore, we tested if purified PKC preparation (Sigma) could phosphorylate p33-derived peptides in vitro. The in vitro kinase assay revealed efficient phosphorylation of a 30 aa-long peptide p33C 205 -234 carrying wt sequences and less efficient phosphorylation of mutant D 210 , whereas mutants A 210 A 211 and D 211 (in the context of p33C 205 -234 ) were not phosphorylated at a detectable level ( Fig. 4A ). Thus, these experiments demonstrated that T 211 residue can be phosphorylated by PKC, but no data for phosphorylation of S 210 residue was obtained. The lack of phosphorylation of S 210 residue in mutant D 211 ( Fig.  4A ) could be due to the sequence change at position 211, because the sequence context of the phosphorylation site is known to affect the efficiency of phosphorylation. To circumvent this problem, we treated the wt p33C 205 -234 peptide with PKC, followed by detection of phosphorylated serine with anti-phosphoserine antibody (Fig. 4C ). This experiment demonstrated that S 210 residue could be phosphorylated by PKC in vitro. Therefore, we conclude that both S 210 and T 211 residues can be phosphorylated by PKC in vitro.
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Effect of phosphorylation of CNV p33 on virus replication based on the use of phosphorylation-mimicking mutants
Because phosphorylation of neutral S and T residues introduces negative charge around these residues, effect of phosphorylation on protein function can be tested by mutating these residues to D, which is negatively-charged. In contrast, the nonphosphorylated status of S and T residues can be mimicked by mutating S and T residues to A, which is neutral. Thus, D mutation mimics the phosphorylated, while A mutation mimics the nonphosphorylated forms of S and T residues as previously demonstrated in numerous assays (Freye-Minks et al., 2003; Jabbur et al., 2001; Jia et al., 2004; Kim et al., 2002; Waigmann et al., 2000) . Another advantage is that both D and A residues are similar in sizes to S and T residues, thus likely minimizing the sterical/structural changes caused by these mutations. In spite of the above advantages, D mutations only ''mimic'' phosphorylation, thus results obtained with D mutants could possibly cause problems unrelated to phosphorylation.
A set of 12 single, double, and triple A/D mutations was introduced at T 205 , S 210 , and T 211 within the p33/p92 open reading frame in an infectious cDNA clone of CNV (Rochon, 1991) . Note that the above mutations changed the sequences of the overlapping p33 and p92 replication proteins ( Fig. 1A) . We then generated CNV RNA transcripts in vitro, followed by electroporation to N. benthamiana protoplasts to test the replication features of the mutated CNV proteins. Total RNA was extracted 12 and 24 h after electroporation and analyzed by Northern blotting. These experiments demonstrated that single and double D for S/T substitutions (at positions S 210 and T 211 ) reduced the ability of CNV to replicate to detectable levels (constructs with single mutations, such as D 210 , and D 211 , and double mutation, D 210 D 211 , Fig. 5A ). In addition, mutant D 205 replicated poorly (<1% at 12, and 7% of wt at 24 h time points, lanes 18 and 26, Fig. 5A ). These data suggest that Fig. 5 . Comparison of accumulation of CNV gRNA carrying phosphorylation-mimicking mutations adjacent to the RPR-motif in p33/p92 gene. The full-length, infectious CNV gRNA (2 Ag) was electroporated into N. benthamiana protoplasts (5 Â 10 5 cells per experiment). Total RNA was isolated, electrophoresed and blotted onto a nylon membrane, followed by probing with 32 P-labeled RNA specific for gCNV (see Materials and methods). The same amount (5 Ag) of total RNA was used for loading onto the gels (based on the estimation of the host ribosomal RNA in ethidium bromide-stained gels). The positions of the CNV gRNA, sgRNA1, and sgRNA2 are depicted on the right. The names of the constructs are shown on the top. The samples were taken 12 and 24 h after electroporation. The experiment was repeated three times. (B) The ability of CNV mutants to support DI-73 RNA replication in trans. The full-length DI-73 RNA (1 Ag) was co-electroporated with the infectious CNV gRNA (2 Ag, mutated or wt) into N. benthamiana protoplasts (5 Â 10 5 cells per experiment). Sample preparation and Northern blotting was done as described in the legend to panel A, except the probing was done with 32 P-labeled RNA specific for DI-73 RNA (see Materials and methods). (C) Accumulation of CNV p33 at 24 hpi. Western blot of total protein extracts was done with anti-p33 antibody.
negative charge(s) at positions S 210 , T 211 , and, to a less extent, at T 205 inhibits CNV replication.
All single and double A mutants (at T 205 , S 210 , and T 211 ) mimicking the nonphosphorylated form of p33/p92 supported replication, albeit with reduced efficiency (34 -58% of wt CNV gRNA) when compared to wt (Fig. 5A ). Even the triple A mutant (construct A 205 A 210 A 211 , accumulation level of 13 -21% of wt, lanes 19 and 27, Fig. 5A ) was replication competent, suggesting that nonphosphorylated residues at positions 205, 210, and 211 are important for the function(s) of replicase proteins in vivo. However, because all these A mutants replicated less efficiently than wt, it is likely that phosphorylation of p33/p92 plays a regulatory role during virus replication (see below).
To demonstrate that the above mutations at T 205 , S 210 , and T 211 in CNV affected replication due to changes in the p33/p92 replication proteins, but not due to altered CNV RNA structure, we tested the ability of the mutated CNV replication proteins to support replication in trans, using a model template, DI-73 RNA (Fig. 5B ). Co-electroporation of DI-73 RNA with the CNV helper (wt or D 210 D 211 ) into plant protoplasts demonstrated that CNV D 210 D 211 did not support replication of DI-73 RNA in trans, indicating that the phosphorylation-mimicking replication protein(s) is not functional in vivo.
To test if the above CNV mutants expressed p33 in comparable amounts, we performed Western blotting on total protein extracts obtained from protoplasts 12, 18, and 24 hpi with an antibody specific for the C-terminal portion of p33 (outside the mutagenized domain of p33). We found that D 210 D 211 p33 was not detectable (Fig. 5C ), whereas the amount of D 210 A 211 was only¨10% of wt p33 (Fig. 6B) . The accumulation of A 210 A 211 p33 was comparable to wt p33. The reduced accumulation of phosphorylation-mimicking p33 mutants in plant protoplasts can be explained by several alternative models including decreased stability and/or production of these p33 forms.
Hypophosphorylation-mimicking p33 mutants affected plus-strand RNA and subgenomic RNA synthesis in vivo
To test for possible regulatory roles of phosphorylation of p33/p92 in replication, we performed time-course experiments in protoplasts with a viable nonphosphorylationmimicking mutant, a hypophosphorylation mutant (i.e., D 210 A 211 carrying only a single D mutation), and the wt (Fig. 6 ). Total RNA samples were prepared from protoplasts and analyzed with Northern blotting as described above. These experiments revealed that nonphosphorylation-mimicking A 210 A 211 and the partial (hypo)-phosphorylationmimicking D 210 A 211 mutants generated 5 -6 times more subgenomic (sg) RNA2 than sgRNA1 at early time points, whereas sgRNA2 was only¨3-fold more abundant than sgRNA1 in the wt CNV infections (Fig. 6A ). Altogether, sgRNA2 was the most abundant viral RNA species in A 210 A 211 and D 210 A 211 infections, in contrast to wt CNV, which produced the gRNA in the largest amount (except at the early time point, Fig. 6A ). These data suggest that phosphorylation status of S 210 and T 211 in p33/p92 could affect the level and ratio of sgRNA1 and sgRNA2 synthesis in CNV infections.
To test if mimicking mutations could also affect minusversus plus-strand synthesis during CNV replication, we took advantage of DI-72 RNA replicon, which produces minus- strand RNA at easily detectable levels (Monkewich et al., 2005) . In this assay, N. benthamiana protoplasts were coelectroporated with wt or mutated (A 210 A 211 , A 205 A 210 A 211 , and D 210 A 211 ) CNV RNA and DI-72 RNA, followed by detection of plus-and minus-strand DI-72 RNA levels in total RNA samples by Northern blotting (Fig. 7) . We observed that DI-72 minus-strand synthesis took place at low levels (10 -20%) between 4 and 12 h postinfection (hpi), followed by increased synthesis between 12 and 24 h in the presence of wt or any of the mutated helper CNV. On the contrary, plusstrand RNA synthesis showed remarkable differences depending on the wt and mutated helper CNV (Fig. 7A ). For example, detectable level of DI-72 plus-strands was observed as early as 6 and 8 hpi in the presence of wt CNV helper, whereas A 205 A 210 A 211 and D 210 A 211 mutants of CNV accumulated DI-72 plus-strands at a detectable level only at 12 hpi (Fig. 7A ). Interestingly, the relative level of minus-strand accumulation (when compared to wt level of minus strands representing 100%) supported by A 205 A 210 A 211 and D 210 A 211 mutants was¨20% higher than the relative level of plus-strand accumulation (Fig. 7C) . The altered ratio between minus and plus-strand accumulation means that the RNA synthesis was less asymmetrical with the above mutants than in the case of wt CNV replicase. Overall, these observations indicate that the phosphorylation status of p33 at positions 205, 210, and 211 might affect the level of asymmetry between plus-versus minus-strand synthesis.
Phosphorylation-mimicking mutations inhibit the function of p33 more than p92 in protoplasts
To test if phosphorylation-mimicking mutations inhibit p33 and/or p92 functions in plant cells, we utilized a twocomponent complementation-based replication assay devel- oped by Oster et al. (1998) , which allows separate mutagenesis of p33 and p92. Expression of p33 and p92 (the p92 ORF contains a tyrosine mutation to suppress termination at the end of p33 ORF, Fig. 8A ) from two separate RNAs leads to efficient replication of DI-p33, whereas CNV-Y replicates poorly in N. benthamiana protoplasts (Figs. 8B -C and . We found that co-expression of the unmodified p92Y with D 210 D 211 mutation in p33 led to undetectable level of DI-p33 replication (Fig. 8B ), suggesting that phosphorylation renders p33 nonfunctional. On the contrary, the D 210 D 211 mutation in p92Y inhibited wt DI-p33 replication by only 50% (Fig. 8C ), suggesting that phosphorylation of p92 RdRp protein at 210 -211 positions interfered with its replication function to a lesser extent than phosphorylation of p33.
Yeast-based tombusvirus replication assay confirms a role for the phosphorylation status of p33 replication protein in tombusvirus replication
To test if the phosphorylation status of p33 affects its stability and/or functions, we took advantage of the availability of TBSV replicon-based replication assay in yeast expressing the CNV p33 and p92 replication proteins, which supports efficient replication of DI-72 RNA (Panavas and Nagy, 2003) . In the yeast system, the expression of p33 and p92 is driven from separate expression vectors via the constitutive ADH1 promoter. The advantage of the yeast replication system is that we can study the replication of the DI-72 RNA without the need of replication and gene expression of the helper virus. This allowed us to re-test if several mimicking mutants of p33 could support tombusvirus replication in yeast.
We found that co-expression of wt p92 together with p33 carrying D for T 211 mutation (see constructs D 211 , D 210 D 211 , A 210 D 211 , D 205 D 210 D 211 , Figs. 9A -C) did not result in DI-72 RNA replication, based on undetectable levels of DI-72 plus-and minus-strands in yeast. Similar mutations at T 205 and S 210 (see constructs D 205 and D 210 , Figs. 9A -C) also reduced replication of DI-72 RNA (down to 12 and 8% of wt levels), but to a lesser extent than observed in plant cells. Western blot analysis of total protein extracts of yeast strains revealed that, unlike in the plant protoplast-based replication assay, the p33 levels in yeast were similar for wt and the mutated p33 ( Fig. 9D ), suggesting that the stability of p33 is not altered by these mutations. Instead, these data indicate that the phosphorylation-mimicking D mutations make p33 less functional/nonfunctional in tombusvirus replication. On the contrary, the nonphosphorylatable A mutations had less pronounced effects on p33 functions (16 -57% level of replication, see constructs A 210 A 211 , A 205 A 210 A 211 , Figs. 9A -C).
We also tested the ability of p33 mutants to support plusversus minus-strand synthesis of the replicon RNA in yeast. Northern blot analysis of total RNA samples revealed that the relative levels of minus-strand (as compared to wt level representing 100%) versus plus-strand accumulation were 2to-5-fold higher in case of four out of five functional p33 mutants (i.e., A 210 A 211 ; A 205 A 210 A 211 ; D 210 A 211 ; and D 205 , Figs. 9B -C) than that observed with wt p33. However, one p33 mutant (i.e., D 210 ) showed lower relative level of minus-strand versus plus-strand synthesis (Figs. 9B -C). Altogether, these data indicate that nonphosphorylation or partial phosphorylation-mimicking mutations in p33 at positions 205, 210, and 211 selectively decrease the level of plus-strand RNA accumulation, likely resulting from less asymmetrical RNA synthesis.
Delayed accumulation of an nonphosphorylation-mimicking mutant in N. benthamiana plants
To test if CNV expressing the nonphosphorylationmimicking A 210 A 211 p33 mutant could replicate with similar efficiency as the wt CNV (expressing phosphorylationcompetent p33) in whole plants, we extracted total RNA from CNV-infected leaves 5, 7, and 14 days after inoculation (dpi). We found that wt CNV accumulated viral-specific RNAs to higher levels than A 210 A 211 did at 5 and 7 dpi (Fig. 10A ), suggesting that virus replication/ accumulation is more robust in wt CNV infections. Interestingly, the difference in accumulation level between wt and A 210 A 211 gRNA was more significant in plants than in protoplasts (2-to-2.5-fold difference in plants at 5 and 7 dpi versus 5% in protoplast at 24 hpi). This might be due to an indirect effect of phosphorylation of wt p33 on cell-tocell movement and/or stability of gRNA. The symptoms caused by the wt CNV infection were also more intensive than in A 210 A 211 infections (Fig. 10B) , and led to the death of most leaves by 14 dpi. On the contrary, symptoms caused by A 210 A 211 were mild and did not lead to necrosis. Interestingly, viral RNA accumulation was 3-fold higher in A 210 A 211 -infected than in wt CNV-infected plants at 14 dpi, likely due to the sickness of wt CNV-infected plants (Fig.  10A) . Altogether, these data demonstrate that the nonphosphorylatable A mutations at positions 210 and 211 in p33 have pronounced effects on the pathogenecity of CNV in N. benthamiana.
Discussion
Detection of phosphorylated replication proteins in plusstrand RNA virus-infected hosts is a challenging task due to the low abundance of viral replication proteins, their localization to less amenable cellular membranes, the dynamic and reversible nature of phosphorylation, and temporally existence of some phosphorylated proteins. By using both anti-phosphothreonine antibody-based Western blot and phosphoprotein-specific staining assays, we demonstrated the accumulation of phosphorylated CNV p33 (and the related TCV p28) replication protein in plants, while we could not detect phosphorylated CNV p92, possibly due to its very low abundance (¨20-fold less than p33; Scholthof et al., 1995) . In addition, we obtained a partially-purified kinase preparation from solubilized membrane-enriched fraction of N. benthamiana, which was able to phosphorylate the CNV p33 replication protein at conserved S/T residues (likely at T 205 , S 210 , and T 211 ) adjacent to the RPR motif, an RNA-binding site Rajendran and Nagy, 2003) . On the contrary, the solubile (cytoplasmic) fraction of cells did not contain kinases capable of phosphorylation of the same region in p33 in vitro (not shown). Because p33 is membraneassociated in cells and tombusvirus replication occurs in membrane-containing compartments (Navarro et al., 2004; Panavas et al., 2005; Panaviene et al., 2004; Rubino and Russo, 1998; Scholthof et al., 1995) , it is likely that phosphorylation of p33 takes place in cellular membranes (peroxisomal membrane for CNV; Panavas et al., 2005) in infected cells. Thus, the kinase present in the membraneenriched fraction is likely responsible for in vivo phosphorylation of p33. This host kinase is functionally similar to PKC, based on phosphorylation site prediction and demonstration that purified PKC preparation could also phosphorylate recombinant p33 at residues S 210 and T 211 in vitro (Fig. 4) . Altogether, we conclude that p33 gets phosphorylated in CNV-infected plants by a membrane-associated host kinase.
The effects of p33 phosphorylation during CNV infection were studied using phosphorylation-mimicking mutants (see rationale in the results section). The advantage of using mimicking mutants is that it simplifies the interpretation of data due to the presence of p33 representing either the ''nonphosphorylated'' (i.e., alanine mutants) or ''phosphorylated'' (aspartic acid mutants) forms of p33 during the entire infection. Disadvantage is that the dynamics of phosphorylation cannot be fully examined with these mutants. Nevertheless, based on data obtained with the mimicking mutants, the model predicting that the nonphosphorylated form of p33 (we refer only to phosphorylation of T 205 , S 210 , and T 211 in the text below) is the functional form is supported, while the fully phosphorylated form of p33 seems to be nonfunctional in replication. Accordingly, in vitro phosphorylation of p33 and phosphorylation-mimicking mutations in p33 (at S 210 and T 211 positions) both inhibited the ability of p33 to bind to the viral RNA in vitro (see Stork et al., 2005) , suggesting that phosphorylation and mimicking mutations had similar effect on p33 function. However, we cannot completely exclude that results obtained with D mutants could possibly cause changes in the structure of p33 unrelated to phosphorylation.
The mimicking mutants were also useful to demonstrate that similar phosphorylation of p92 RdRp protein (at T 205 , S 210 , and T 211 ), which overlaps with p33 within its Nterminus, had only limited effect on its activity in protoplasts. Thus, we suggest that phosphorylation at T 205 , S 210 , and T 211 mainly affects p33 function(s) during CNV infections. Phosphorylation of p33 and p92 at additional amino acid residues was not addressed in this paper. In addition to the nonphosphorylated and fully phosphorylated forms of p33, we suggest that hypophosphorylation of p33 at either T 205 , S 210 , or T 211 positions might affect its activity/function. For example, we observed changes in the ratio of sgRNA1 versus sgRNA2 and of plus-versus minus-strand levels (i.e., strand asymmetry was reduced) with mimicking mutants affecting only one or two of the predicted phosphorylation sites. These observations open up the possibility that hypophosphorylation of p33 might be involved in (i) timing and/or fine tuning of subgenomic RNA synthesis (sgRNA1 versus sgRNA2) and (ii) controlling the timing and/or ratio of plus-versus minus-strand synthesis. For example, hypophosphorylation of p33 might modify the activity of the CNV replicase, affecting the timing of production of different viral RNA species and the ratio of replication products. In contrast, full phosphorylation of p33 (especially phosphorylation of T 211 seems to be the most critical) might shut down replication, which could be beneficial for viral RNA encapsidation, cell-to-cell movement, and other processes by releasing the viral RNA from replication (see the accompanying paper by Stork et al., 2005) . Indeed, the nonphosphorylated A 210 A 211 mutant showed delay in gRNA accumulation in systemically infected leaves when compared to the wt CNV, suggesting less efficient virus spread in plants and/or decreased stability of mutant A 210 A 211 gRNA.
The amount of p33 replication protein was not the same in infections with wt and phosphorylation-mimicking CNV mutants in N. benthamiana protoplasts (Figs. 5C and 6B). For example, protoplasts containing a replication incompetent mutant (D 210 D 211 ) and an inefficiently replicating mutant (D 210 A 211 ) accumulated p33 at undetectable and reduced levels, respectively ( Figs. 5C and 6B ). This suggests that phosphorylation-mimicking aspartic acid mutations (and analogously phosphorylation) might promote rapid p33 degradation, thus affecting the stability of p33. Although we cannot fully exclude that the above D mutations facilitate p33 degradation, this model is not supported by the observation that the amounts and stability of wt and phosphorylation-mimicking D mutants of p33 were comparable in yeast, expressing these proteins constitutively from plasmids (Fig. 9D ). Alternatively, it is possible that reduced accumulation of p33 carrying the phosphorylation-mimicking mutations is due to the production of a limited amount of new CNV RNA progeny in cells. We propose that some of the new CNV RNA progeny could participate in new rounds of translation to boost p33/p92 production, and thus replication, in infected cells. The proposed translational boost might not take place for CNV RNA expressing p33 with the phosphorylation-mimicking mutations that produce only limited amount of new progeny plus-strands.
The phosphorylation sites studied in this paper are located adjacent to the positively charged RNA-binding domain in p33 (Fig. 1B) . Therefore, it is possible that the observed effects of the phosphorylation-mimicking mutants on CNV replication are due to altered RNA-binding capacity of p33. Accordingly, we show in the accompanying paper (Stork et al., 2005) the inhibitory effect of phosphorylation of these sites on RNA-binding by the recombinant p33. Thus, phosphorylation of p33 is likely an important step in CNV replication by affecting replicase and template interactions.
Materials and methods
Detection of phosphorylated p33 and p28 replication proteins by Western blotting using phosphothreonine specific antibody or by staining with phosphoprotein-specific dye Leaves (2 g) of N. benthamiana plants systemically infected with CNV and TCV, respectively, were used to obtain the membrane-enriched and soluble fractions as described (Panaviene et al., 2004) , except we included phosphatase inhibitor mix containing 25 mM NaF, 10 mM benzamidine, 10 mM sodium orthovanadate. 1/10th of the obtained membrane-enriched fraction was loaded on a 10% SDS-PAGE gels, electrophoresed, transferred to PVDF membranes, followed by using anti-phosphothreonine and anti-phosphoserine antibodies as recommended by the manufacturer (Research Diagnostic, Inc.).
The second method to detect phosphorylated p33 in CNV-infected N. benthamiana was based on using the phosphoprotein specific Pro-Q Diamond dye from Molecular Probes. First, we prepared the membrane-enriched fraction (see above), followed by solubilization of membrane-bound proteins with 2% Triton X-100 as described (Nagy and Pogany, 2000; Panaviene et al., 2004) . Anti-p33 antibody (prepared against CVGYLKNT-PENRLIY peptide, Sigma-Genosys) was then added to the sample, followed by incubation in the cold room and then addition of protein A (Sigma) and further incubation for 60 min. The pellet was recovered after centrifugation, washed three times, and then loaded on an SDS-PAGE gel. The gel was then fixed overnight with 200 ml 10% acetic acid (glacial) and 50% methanol, followed by three time wash with 200 ml deionized water for 15 min. Staining of the gel was done overnight in the dark with 50 ml Pro-Q Diamond dye as recommended by the manufacturer (Molecular Probes). Destaining was done with 200 ml 10% methanol and 7% acetic acid for 30 min. Images of gels were taken when illuminated with 302 nm UV light.
Preparation of host kinase-containing fraction from N. benthamiana and in vitro phosphorylation of p33
Young leaves (5 g) of uninfected N. benthamiana were used to obtain the membrane-enriched fraction (see above), followed by solubilization with 4% Triton X-100 exactly as described for preparation of CNV replicase (Panaviene et al., 2004) . The solubilized membrane-enriched preparation was passed through Sephadex G-25 resin (Amersham). To reduce the background in subsequent assays, the obtained host kinase preparation was mixed with phosphorylation buffer (0.1 M HEPES pH 7.4, 10 mM EDTA, 5 mM DTT, 50 mM MgCl 2 ) in the presence of 1 mM ATP to allow phosphorylation of any phosphorylatable proteins that might be present in the preparation for 20 min at room temperature (RT). This was followed by removal of ATP on a Sephadex G-25 column.
To test phosphorylation of CNV p33 in vitro by the above kinase-containing plant membrane preparation, we selected two purified recombinant p33-derived peptides, termed C10 (p33 181 -240 ) and C11 (p33 211 -240 ) (Rajendran and Nagy, 2003) , expressed in E. coli. The cleavage of the proteins was done with Factor Xa protease (NEB) as described (Rajendran and Nagy, 2003) . The in vitro phosphorylation reaction was made in 20 Al volume in the phosphorylation buffer (see above), plus 1 Al g 32 P-ATP (7000 Ci/mmol, 0.05 mCi), 2 Al kinase-containing plant membrane fraction, and 3 Ag of p33derived peptide. After incubation for 20 min, the samples were run in SDS-PAGE gels, stained with coomassie blue, dried and exposed to a phospho-storage screen, and imaged with a PhosphorImager.
In vitro phosphorylation of p33 with PKC
The affinity-purified p33 mutants (200 Ag/ml, expressed in E. coli) (Rajendran et al., 2002) , carrying or lacking the T 205 , S 210 , and T 211 positions, were phosphorylated in 20 Al volume containing PKC-phosphorylation buffer (20 mM HEPES, 0.03% triton X-100, 4 mM MOPS, 5 mM hglycerol phosphate, 1 mM EGTA, 0.2 mM Na-orthovanadate, 0.2 mM DTT), 0.1 mM ATP (unlabeled), 5 Al PKC lipid activator (Upstate), 1 Al 2 mM CaCl, 2.5 Al g 32 P-ATP (7000 Ci/mmol, 0.125 mCi), and 0.5 Al PKC (Sigma), for 15 min at room temperature. Afterwards, the samples were boiled in SDS-PAGE running buffer for 3 min and loaded onto a large 10% SDS-PAGE gel (Bio-Rad protean II xi). The electrophoresis was performed at 200 V for 6 h, followed by staining with coomassie blue, drying, and then scanning by a PhosphorImager.
Construction and testing of the phosphorylation-mimicking mutants of CNV p33 in N. benthamiana protoplasts and plants
To make site-directed mutations that replaced S/T residues with A/D residues, we used standard Quick Change XL Site-Directed Mutagenesis Kit (Stratagene) as described before based on an infectious CNV clone (Rochon, 1991) . The mutant clones were confirmed by sequencing, using Beckman Coulter DTCS Quickstart Kit and primer #958 (5V-CCGGCACGGGAGCTCAAGGG-TAAGGA).
Full-length RNA transcripts of CNV (Rochon, 1991) , DI-72, and DI-73 (White and Morris, 1994a, 1994b) were prepared using standard in vitro transcription reaction with T7 RNA polymerase on SmaI linearized DNA templates. N. benthamiana protoplasts were prepared as described before . Protoplasts were divided into aliquots (5 Â 10 5 protoplasts) and electroporated with 5 Ag of wt or mutated CNV gRNA and 1 Ag of DI RNA (when the goal was to test DI RNA replication). After electroporation, protoplasts were incubated in the dark at 22 -C.
N. benthamiana plants were rub inoculated with 3 Ag of wt or mutated CNV gRNA. Inoculated plants were kept in the green house. Samples were taken after 5, 7, and 14 dpi.
CNV RNA extraction and Northern blotting
Total RNA was prepared from protoplast or plants using a standard phenol/chloroform method (Kong et al., 1997; Nagy et al., 2001) and the samples were electrophoresed in 1.2% agarose (in case of gRNA) or 4% polyacrylamide/8 M urea gels (for DI-72 RNA). The RNA was then transferred from the gels to Hybond XL membrane (Amersham-Pharmacia) by electrotransfer and hybridized with CNVspecific probes for the 3V noncoding region as described . Hybridization was done in ULTRAhyb hybridization buffer at 68 -C as recommended by the supplier (Ambion). The riboprobes were made in an in vitro transcription reaction with T7 RNA polymerase in the presence of [ 32 P]UTP as described. The CNV DNA template was obtained using PCR with pair of primers #16 (GTAA-TACGACTCACTATAGGGCTGCATTTCTGCAATGTTC) and #312 (GCTGTCAGTCTAGTGGA) for detection of plus-strands, and with #31 (GTAATACGACTCACTATAG-GAAATTCTCCAGGATTTC) and #806 (CCGTCTAGAG-TCGTCGTTTACTGGAAGTTAC) for detection of minusstrands. The template for detection of DI-72 RNA (+) and (À) strands (corresponding to RIII/RIV) was obtained with PCR using primers #1165 (AGCGAGTAAGACCAGACT-CTTCA) and #22 (GTAATACGACTCACTATAGGGCTG-CATTTCTGCAATGTTCC) versus #157 (GGGTTTCATAQ GAAAAGAAAACAAAACC) and #18 (GTAATACGACT-CACTATAGGAGAAAGCGAGTAAGACAG), respectively.
The two component, trans-complementation assay was performed in N. benthamiana protoplasts with selected mutants as described earlier . The mutant clones were confirmed by sequencing, as described above.
Western blot analysis
Total proteins from N. benthamiana plant or protoplasts infected with CNV were prepared as described (Panaviene et al., 2004) . The samples were run in 10% SDS-PAGE, followed by transfer onto PVDF membrane (Bio-Rad). Immunodetection of p33 protein in the Western blot was performed by using anti-p33 antibody (generous gift of H. Scholthof).
Analysis of replicon RNA accumulation in yeast
S. cerevisiae strain INVSc1 (Invitrogen) transformed with three plasmids [i.e., pGAD-His92, pGBK-His33 and pYC-DI-72(+)Rz; Panaviene et al., 2004) was grown in SC-ULT-medium containing 2% galactose for 24 h at 30 -C (Panavas and Nagy, 2003) . To extract total RNA from yeast, equal volumes of RNA extraction buffer (50 mM sodium acetate, pH 5.3, 10 mM EDTA, 1% SDS) and watersaturated phenol were added to the pelleted cells (Panavas and Nagy, 2003) . Agarose gel electrophoresis and Northern blotting were as described above (Pogany et al., 2005) .
Western blot to detect accumulation levels of His-tagged p33 was performed as described earlier (Pogany et al., 2005) using monoclonal anti-His antibodies (Amersham) and secondary alkaline phosphatase-conjugated anti-mouse antibody (Sigma). Western blots were developed using BCIP and NBT (Sigma).
